News & Events

• January 5, 2023
  

  Using Real World Data from CURE ID to Identify Drug Repurposing Opportunities in Mycology: Impact of Climate Change

• December 26, 2022
  

  Polycystic Kidney Disease Drug Development: A Conference Report

• December 22, 2022
  

  The publication quality of laboratory values in clinical studies in neonates

• December 20, 2022
  

  C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System

  The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for allograft loss.

• December 20, 2022
  

  C-Path Receives Letter of Support from EMA for Parkinson’s Disease Clinical Trial Simulation Platform

  C-Path today announced that the European Medicines Agency (EMA) has issued a letter of support for the Critical Path for Parkinson’s (CPP) Consortium’s Model-based Clinical Trial Simulation Platform to Optimize Design of Efficacy Evaluation Studies in Parkinson’s Disease (PD).